Centessa Pharmaceuticals (UK)

Centessa Pharmaceuticals is a clinical-stage biotechnology company developing orexin receptor 2 (OX2R) agonists for sleep-wake disorders, such as narcolepsy and idiopathic hypersomnia. Its lead programs include ORX750, ORX142 and ORX489. The company aims to deliver transformative medicines to patients with neurological and neuropsychiatric disorders.